HUMACYTE INC (HUMA)
US44486Q1031 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.49M -75.93% | 1.26M -15.44% | 1.57M 24.60% | 58.283K -100.00% | 218.576K | 14.291M 6,438.24% | 126.45M 784.82% | 284.54M 125.02% | 530.41M 86.41% | 735.56M 38.68% | 1.194B 62.33% | 2.548B 113.40% | |
| EBITDA YoY % growth | -56.25M 28.74% | -72.96M -29.71% | -76.37M -4.67% | -98.634M -20.90% | -83.232M 9.85% | -60.486M 27.33% | 714K 101.18% | 12.75M 1,685.71% | 68.952M 440.80% | 130.25M 88.90% | 212.47M 63.12% | 308.04M 44.98% | |
| EBIT YoY % growth | -64.6M 24.61% | -81.2M -25.70% | -84.58M -4.16% | -100.904M -18.29% | -118.668M -18.61% | -114.379M 3.61% | -19.353M 83.08% | 139.01M 818.28% | 424.17M 205.14% | 636.08M 49.96% | 909.07M 42.92% | 2.345B 157.96% | |
| Operating Margin | -4,335.57% | -6,444.44% | -5,387.26% | -173,128.65% | -54,291.38% | -800.36% | -15.31% | 48.85% | 79.97% | 86.48% | 76.14% | 92.03% | |
| EPS YoY % growth | N/A | -0.51 | -0.13 74.51% | -1.08 -723.08% | -1.38 -28.96% | -0.88 36.11% | -0.19 78.21% | 0.85 542.47% | 2.88 239.01% | 4.11 42.65% | 5.96 44.91% | 10.50 76.20% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 -6.86% | -0.24 16.47% | -0.24 50.59% | -0.24 26.59% | -0.24 4.55% |
| Revenue Q2Q % growth | 218.576K | 2.627M | 3.514M | 4.315M | 5.539M 2,434.13% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -30.746M -17.43% | -30.886M -16.21% | -30.594M -3.71% | -31.426M -3.95% | -31.201M -1.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.33 -32.00% | -0.25 | -0.08 | -30.16% |
| Q2 2024 Q2Q % growth | -0.48 -118.18% | -0.24 | -0.24 | -97.73% |
| Q1 2024 Q2Q % growth | -0.29 19.44% | -0.23 | -0.06 | -26.36% |
| Q4 2023 Q2Q % growth | -0.24 -500.00% | -0.25 | 0.01 | 3.91% |
| Q3 2023 Q2Q % growth | -0.25 | -0.26 | 0.01 | 3.25% |
| Q2 2023 Q2Q % growth | -0.22 -162.86% | -0.22 | 0.00 | 1.81% |
| Q1 2023 Q2Q % growth | -0.36 -89.47% | -0.21 | -0.15 | -68.39% |
| Q4 2022 Q2Q % growth | -0.04 -109.76% | -0.24 | 0.20 | 83.31% |
| Q3 2022 Q2Q % growth | -0.25 65.28% | -0.22 | -0.03 | -14.00% |
| Q2 2022 Q2Q % growth | 0.35 | -0.22 | 0.57 | 257.16% |
| Q1 2022 Q2Q % growth | -0.19 5.00% | -0.21 | 0.02 | 9.87% |
| Q4 2021 Q2Q % growth | 0.41 | -0.21 | 0.62 | 296.08% |
| Q3 2021 Q2Q % growth | -0.72 | -0.21 | -0.51 | -243.78% |
| Q2 2021 Q2Q % growth | 0.00 | -0.58 | 0.58 | 100.00% |
| Q1 2021 Q2Q % growth | -0.20 | -0.92 | 0.72 | 78.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 58.283K | -58.283K | -100.00% | |
| Q3 2023 Q2Q % growth | -100.00% | 68.003K | -68.003K | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | 68.003K | -68.003K | -100.00% |
| Q1 2023 Q2Q % growth | -100.00% | 168.912K | -168.912K | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 200.093K | -200.093K | -100.00% |
| Q3 2022 Q2Q % growth | 30K -87.50% | 207.57K | -177.57K | -85.55% |
| Q2 2022 Q2Q % growth | 1.3M 88.41% | 208.59K | 1.091M | 523.23% |
| Q1 2022 Q2Q % growth | 230K 43.75% | 250.308K | -20.308K | -8.11% |
| Q4 2021 Q2Q % growth | 180K 50.00% | 259.08K | -79.08K | -30.52% |
| Q3 2021 Q2Q % growth | 240K -73.63% | 379.103K | -139.103K | -36.69% |
| Q2 2021 Q2Q % growth | 690K | 102K | 588K | 576.47% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.05% | -11.02% | -12.55% |
| Revenue | 0% | -91.33% | -31.82% | -48.98% |